<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="letter" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Mediterr J Rheumatol</journal-id><journal-id journal-id-type="iso-abbrev">Mediterr J Rheumatol</journal-id><journal-id journal-id-type="pmc-domain-id">3789</journal-id><journal-id journal-id-type="pmc-domain">medjrheum</journal-id><journal-id journal-id-type="publisher-id">MJR</journal-id><journal-title-group><journal-title>Mediterranean Journal of Rheumatology</journal-title></journal-title-group><issn pub-type="epub">2529-198X</issn><publisher><publisher-name>Greek Rheumatology Society and Professional Association of Rheumatologists</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10075368</article-id><article-id pub-id-type="pmcid-ver">PMC10075368.1</article-id><article-id pub-id-type="pmcaid">10075368</article-id><article-id pub-id-type="pmcaiid">10075368</article-id><article-id pub-id-type="pmid">37034372</article-id><article-id pub-id-type="doi">10.31138/mjr.33.4.478</article-id><article-id pub-id-type="publisher-id">MJR-33-4-478</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Letter to the Editor</subject></subj-group></article-categories><title-group><article-title>Low Folate Levels are Associated with Strokes and Less Venous Thromboses in Primary Antiphospholipid Syndrome</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Carvalho</surname><given-names initials="JF">Joz&#233;lio Freire</given-names></name><xref rid="AFF1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="C1" ref-type="corresp"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shoenfeld</surname><given-names initials="Y">Yehuda</given-names></name><xref rid="AFF2" ref-type="aff">
<sup>2</sup>
</xref></contrib><aff id="AFF1"><label>1</label>Institute for Health Sciences from Federal University of Bahia, Salvador, BA, Brazil,</aff><aff id="AFF2"><label>2</label>Zabludowicz Research Centre for Autoimmune Diseases, Sheba Medical Centre, Israel</aff></contrib-group><author-notes><corresp id="C1"><bold>Corresponding Author:</bold> Joz&#233;lio Freire de Carvalho, Institute for Health Sciences from Federal University of Bahia, Rua das Violetas, 42, ap. 502, Pituba, Salvador, BA, Brazil, Tel.: +5571 99187 1169, E-mail:<email>jotafc@gmail.com</email></corresp></author-notes><pub-date pub-type="collection"><month>12</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>23</day><month>11</month><year>2022</year></pub-date><volume>33</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">432852</issue-id><fpage>478</fpage><lpage>479</lpage><history><date date-type="received"><day>04</day><month>12</month><year>2021</year></date><date date-type="accepted"><day>20</day><month>1</month><year>2022</year></date></history><pub-history><event event-type="pmc-release"><date><day>23</day><month>11</month><year>2022</year></date></event><event event-type="pmc-live"><date><day>06</day><month>04</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-28 09:25:45.543"><day>28</day><month>09</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2022 The Mediterranean Journal of Rheumatology (MJR)</copyright-statement><copyright-year>2022</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under and Creative Commons Attribution-NonCommercial 4.0 International License.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="MJR-33-4-478.pdf"/><kwd-group><kwd>antiphospholipid syndrome</kwd><kwd>thrombophilia</kwd><kwd>folic acid</kwd><kwd>vitamin</kwd><kwd>stroke</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec><title>To the editor,</title><p>Antiphospholipid syndrome (APS) is associated with venous and/or arterial thromboses, recurrent miscarriages, and/or thrombocytopenia.<sup><xref rid="B1" ref-type="bibr">1</xref></sup> In addition, it is known that some patients may develop cardiovascular events linked to traditional and non-traditional risk factors.<sup><xref rid="B2" ref-type="bibr">2</xref></sup> Low folate levels have been associated with comorbidities, including strokes.<sup><xref rid="B3" ref-type="bibr">3</xref></sup> However, we were unable to find any previous study which has evaluated the clinical and laboratory associations of FL in primary APS patients. Therefore, it would be reasonable to evaluate if serum folate levels (SFL) might be connected to clinical (strokes) or laboratory features of APS, independently of homocysteine and vitamin B12 levels.</p><p>A sample of 23 primary APS (pAPS) was studied to verify clinical and serological differences between individuals with normal and low SFL. Twenty-three pAPS females (Sidney criteria)<sup><xref rid="B4" ref-type="bibr">4</xref></sup> were enrolled for this cross-sectional analysis, which excluded individuals with associated connective tissue disease and using folate supplementation. Data were assessed by a chart review and clinical examinations. IgG and IgM anticardiolipin antibodies (ACL) were tested at least twice using ELISA (Inova Diagnostics, Inc., San Diego, USA). In addition, lupus anticoagulant (LAC) was determined according to the international guidelines.<sup><xref rid="B5" ref-type="bibr">5</xref></sup> Serum folate levels were measured in a Beckman-Coulter DxI 800 chemiluminescent immunoassay, and normal levels were considered above 6.8 ng/mL.<sup><xref rid="B6" ref-type="bibr">6</xref></sup></p><p>In this sample, 4/23 (17.4%) have had low SFL (group 1), and 19/23 (82.6%) did not (group 2). Median SFL between the groups were significantly different (4.85 [3.5&#8211;5.8 ng/mL] vs. 12.1 [7.4&#8211;20 ng/mL], p=0.0003). Group 1 patients were older (50 [42&#8211;52 years] vs. 40 [21&#8211;54 years], p=0.04), had more Sneddon&#8217;s syndrome (75% vs. 21%, p=0.04), strokes (75% vs. 26.3$, p=0.05), live-do reticularis (75% vs. 21%, p=0.02), acute myocardial infarction (25% vs. 0, p=0.01), family history of coronary diseases (50% vs. 5.2%, p=0.03), and currently were under low molecular weight heparin (75% vs. 26.3%, p=0.03) in comparison with group 2. On the other hand, group 1 had less venous thromboses event (0 vs. 47.3%, p=0.01), and consumed less glucocorticoid (0 vs. 58%, p=0.017) than group 2. No other variable was significantly different between groups 1 and 2, including homocysteine and vitamin B12 levels (p&gt; 0.05). We proceeded a logistic regression analysis, and the independent variables associated with low folate levels were stroke (p=0.03), and less venous thrombosis (p=0.02).</p><p>The present study found for the first time a positive association of low folate levels with strokes, and a negative association with venous thromboses in patients with pAPS. Previous studies of the literature have shown a positive link between low folate levels and stroke in hypertensive patients.<sup><xref rid="B3" ref-type="bibr">3</xref></sup> The risk of first ischemic stroke was significantly higher in hypertensive patients with low levels of both folate and B<sub>1,</sub> and the authors suggesting a folic acid supplementation for this risk population. Furthermore, a meta-analysis with 55,764 subjects studied concluded that folic acid supplementation may prevent stroke.<sup><xref rid="B7" ref-type="bibr">7</xref></sup> It is logical to think that low folate can induce hyper-homocysteine, although we did not find this typical association in the present study. One hypothesis is that low folate creates an inflammatory environment due to low methylation. It is well known that folic acid has a direct antioxidant, antithrombotic, and endothelium-protective effects and has a significant role in DNA synthesis or repair.<sup><xref rid="B8" ref-type="bibr">8</xref></sup> Ultimately might induce endothelial damage, and a patient may become prone to stroke. This study has the great advantage of including pAPS patients exclusively, excluding other connective tissue diseases, avoiding the consequences of associated diseases. However, a limitation of the present study is the relatively low number of participants, and it might bring type 1 errors in the interpretation of the results.</p><p>In conclusion, 17% of the PAPS patients had low folate levels. Serum folate levels in pAPS is linked to stroke and less venous events. In patients with folate levels below the normal range, we recommend supplementing folic acid for these APS subjects.</p></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>We are thankful to Sergio Dias Ribeiro for the English revision of the manuscript.</p></ack><sec><title>FUNDING SOURCES</title><p>None.</p></sec><sec sec-type="COI-statement"><title>CONFLICT OF INTEREST</title><p>The authors declare no conflict of interest.</p></sec><sec><title>ETHICAL STATEMENT</title><p>The authors declare that they followed the World Medical Association Declaration of Helsinki in this study. Informed consent was obtained from all participants to participate in this study and for this publication.</p></sec><ref-list><title>REFERENCES</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Carvalho</surname><given-names>JF</given-names></name><name name-style="western"><surname>Levy</surname><given-names>RA</given-names></name><name name-style="western"><surname>Shoenfeld</surname><given-names>Y.</given-names></name></person-group><article-title>Antiphospholipid syndrome and antibodies</article-title>. <source>J Immunol Res</source><year>2014</year>;<volume>2014</volume>:<fpage>942869</fpage>.<pub-id pub-id-type="pmid">25202712</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2014/942869</pub-id><pub-id pub-id-type="pmcid">PMC4151358</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mazidi</surname><given-names>M</given-names></name><name name-style="western"><surname>Katsiki</surname><given-names>N</given-names></name><name name-style="western"><surname>Mikhailidis</surname><given-names>DP</given-names></name><name name-style="western"><surname>Banach</surname><given-names>M</given-names></name><collab>Lipid and Blood Pressure Meta-Analysis Collaboration (LBPMC) Group</collab></person-group>. <article-title>Associations of serum uric acid with total and cause-specific mortality: Findings from individuals and pooling prospective studies</article-title>. <source>Atherosclerosis</source><year>2020</year><month>Mar</month>;<volume>296</volume>:<fpage>49</fpage>&#8211;<lpage>58</lpage>.<pub-id pub-id-type="pmid">32032905</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.atherosclerosis.2019.07.019</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qin</surname><given-names>X</given-names></name><name name-style="western"><surname>Spence</surname><given-names>JD</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sun</surname><given-names>N</given-names></name><etal/></person-group><article-title>Interaction of serum vitamin B12 and folate with <italic toggle="yes">MTHFR</italic> genotypes on risk of ischemic stroke</article-title>. <source>Neurology</source><year>2020</year><month>Mar</month><day>17</day>;<volume>94</volume>(<issue>11</issue>):<fpage>e1126</fpage>&#8211;<lpage>e1136</lpage>.<pub-id pub-id-type="pmid">31932513</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000008932</pub-id><pub-id pub-id-type="pmcid">PMC7220236</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miyakis</surname><given-names>S</given-names></name><name name-style="western"><surname>Lockshin</surname><given-names>MD</given-names></name><name name-style="western"><surname>Atsumi</surname><given-names>T</given-names></name><name name-style="western"><surname>Branch</surname><given-names>DW</given-names></name><name name-style="western"><surname>Brey</surname><given-names>RL</given-names></name><name name-style="western"><surname>Cervera</surname><given-names>R</given-names></name><etal/></person-group><article-title>International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)</article-title>. <source>J Thromb Haemost</source><year>2006</year><month>Feb</month>;<volume>4</volume>(<issue>2</issue>):<fpage>295</fpage>&#8211;<lpage>306</lpage>.<pub-id pub-id-type="pmid">16420554</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1538-7836.2006.01753.x</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wisl&#248;ff</surname><given-names>F</given-names></name><name name-style="western"><surname>Jacobsen</surname><given-names>EM</given-names></name><name name-style="western"><surname>Liest&#248;l</surname><given-names>S.</given-names></name></person-group><article-title>Laboratory diagnosis of the antiphospholipid syndrome</article-title>. <source>Thromb Res</source><year>2002</year>;<volume>108</volume>:<fpage>263</fpage>&#8211;<lpage>71</lpage>.<pub-id pub-id-type="pmid">12676184</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0049-3848(02)00400-0</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>Y</given-names></name><name name-style="western"><surname>Peng</surname><given-names>D</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name><name name-style="western"><surname>Huang</surname><given-names>C</given-names></name><name name-style="western"><surname>Luo</surname><given-names>J.</given-names></name></person-group><article-title>Serum high concentrations of homocysteine and low levels of folic acid and vitamin B12 are significantly correlated with the categories of coronary artery diseases</article-title>. <source>BMC Cardiovasc Disord</source><year>2017</year><month>Jan</month><day>21</day>;<volume>17</volume>(<issue>1</issue>):<fpage>37</fpage>.<pub-id pub-id-type="pmid">28109191</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12872-017-0475-8</pub-id><pub-id pub-id-type="pmcid">PMC5251223</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Qin</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Sun</surname><given-names>N</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Q</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name><etal/></person-group><article-title>Efficacy of folic acid supplementation in stroke prevention: new insight from a meta-analysis</article-title>. <source>Int J Clin Pract</source><year>2012</year><month>Jun</month>;<volume>66</volume>(<issue>6</issue>):<fpage>544</fpage>&#8211;<lpage>51</lpage>.<pub-id pub-id-type="pmid">22607506</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1742-1241.2012.02929.x</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verhaar</surname><given-names>MC</given-names></name><name name-style="western"><surname>Stroes</surname><given-names>E</given-names></name><name name-style="western"><surname>Rabelink</surname><given-names>TJ.</given-names></name></person-group><article-title>Folates and cardiovascular disease</article-title>. <source>Arterioscler Thromb Vasc Biol</source><year>2002</year>;<volume>22</volume>:<fpage>6</fpage>&#8211;<lpage>13</lpage>.<pub-id pub-id-type="pmid">11788454</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/hq0102.102190</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>